Antiviral Activity of RhoA-Derived Peptides against Respiratory Syncytial Virus Is Dependent on Formation of Peptide Dimers

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 11, 2003, Pages 3470-3477

  Budge, Philip J ^a,b   Lebowitz, Jacob ^c   Graham, Barney S ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; GUANOSINE TRIPHOSPHATASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SYNTHETIC PEPTIDE;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DIMERIZATION; DRUG POTENCY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEDIMENTATION; VIRUS INHIBITION;

ALGORITHMS; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CELL SURVIVAL; CHROMATOGRAPHY, GEL; CYSTEINE; DITHIONITROBENZOIC ACID; HUMANS; OXIDATION-REDUCTION; PEPTIDES; PLAQUE ASSAY; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RHOA GTP-BINDING PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; SULFHYDRYL REAGENTS; ULTRACENTRIFUGATION;

EID: 0242322628     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.11.3470-3477.2003     Document Type: Article

References (30)

1. Andreu, D., F. Albericio, N. A. Sole, M. C. Munson, M. Ferrer, and G. Barany. 1994. Formation of disulfide bonds in synthetic peptides and proteins. Methods Mol. Biol. 35:91-169.
2. Baba, M., D. Schols, E. Declerco, R. Pauwels, M. Nagy, J. Gyorgyiedelenyi, M. Low, and S. Gorog. 1990. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus-replication and giant-cell formation. Antimicrob. Agents Chemother. 34:134-138.
3. Bourgeois, C., J. B. Bour, K. Lidholt, C. Gauthray, and P. Pothier. 1998. Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. J. Virol. 72:7221-7227.
4. Collins, P. L., R. M. Chanock, and B. R. Murphy. 2001. Respiratory syncytial virus, p. 1443-1485. In P. M. Howley and D. M. Knipe (ed.), Fields virology, vol. 1, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
5. Feldman, S. A., S. Audet, and J. A. Beeler. 2000. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J. Virol. 74:6442-6447.
6. Feldman, S. A., R. M. Hendry, and J. A. Beeler. 1999. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J. Virol. 73:6610-6617.
7. Gorman, J. J., J. L. McKimm-Breschkin, R. S. Norton, and K. J. Barnham. 2001. Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein. J. Biol. Chem. 276:38988-38994.
8. Graham, B. S., M. D. Perkins, P. F. Wright, and D. T. Karzon. 1988. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26:153-162.
9. Hallak, L. K., P. L. Collins, W. Knudson, and M. E. Peeples. 2000. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271:264-275.
10. Heminway, B. R., Y. Yu, Y. Tanaka, K. G. Perrine, E. Gustafson, J. M. Bernstein, and M. S. Galinski. 1994. Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion. Virology 200:801-805.
11. Ihara, K., S. Muraguchi, M. Kato, T. Shimizu, M. Shirakawa, S. Kuroda, K. Kaibuchi, and T. Hakoshima. 1998. Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue. J. Biol. Chem. 273:9656-9666.
12. Ikeda, S., J. Neyts, S. Verma, A. Wickramasinghe, P. Mohan, and E. De Clercq. 1994. In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion. Antimicrob. Agents Chemother. 38:256-259.
13. Karron, R. A., D. A. Buonagurio, A. F. Georgiu, S. S. Whitehead, J. E. Adamus, M. L. Clements-Mann, D. O. Harris, V. B. Randolph, S. A. Udem, B. R. Murphy, and M. S. Sidhu. 1997. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. USA 94:13961-13966.
14. Krusat, T., and H. J. Streckert. 1997. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch. Virol. 142:1247-1254.
15. Lambert, D. M., S. Barney, A. L. Lambert, K. Guthrie, R. Medinas, D. E. Davis, T. Bucy, J. Erickson, G. Merutka, and S. R. Petteway, Jr. 1996. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 93:2186-2191.
16. Lebowitz, J., M. S. Lewis, and P. Schuck. 2002. Modern analytical ultracentrifugation in protein science: a tutorial review. Protein Sci. 11:2067-2079.
17. Longenecker, K., P. Read, U. Derewenda, Z. Dauter, X. Liu, S. Garrard, L. Walker, A. V. Somlyo, R. K. Nakamoto, A. P. Somlyo, and Z. S. Derewenda. 1999. How RhoGDI binds Rho. Acta Crystallogr. D Biol. Crystallogr. 55(Pt 9):1503-1515.
18. Luscher-Mattli, M. 2000. Polyanions - a lost chance in the fight against HIV and other virus diseases? Antivir. Chem. Chemother. 11:249-259.
19. Maesaki, R., K. Ihara, T. Shimizu, S. Kuroda, K. Kaibuchi, and T. Hakoshima. 1999. The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN/PRK1. Mol. Cell 4:793-803.
20. Pastey, M. K., J. E. Crowe, Jr., and B. S. Graham. 1999. RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation. J. Virol. 73:7262-7270.
21. Pastey, M. K., T. L. Gower, P. W. Spearman, J. E. Crowe, Jr., and B. S. Graham. 2000. A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nat. Med. 6:35-40.
22. Prince, G. A. 2001. An update on respiratory syncytial virus antiviral agents. Expert Opin. Investig. Drugs 10:297-308.
23. Rittinger, K., P. A. Walker, J. F. Eccleston, S. J. Smerdon, and S. J. Gamblin. 1997. Structure at 1.65 A of RhoA and its GTPase-activating protein in complex with a transition-state analogue. Nature 389:758-762.
24. Russell, C. J., T. S. Jardetzky, and R. A. Lamb. 2001. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J. 20:4024-4034.
25. 2+-free form of RHOA complexed with GDP. Implications for the GDP/GTP exchange mechanism. J. Biol. Chem. 275:18311-18317.
26. Tam, J. P., C. R. Wu, W. Liu, and J. W. Zhang. 1991. Disulfide bond formation in peptides by dimethyl-sulfoxide-scope and applications. J. Am. Chem. Soc. 113:6657-6662.
27. Techaarpornkul, S., N. Barretto, and M. E. Peeples. 2001. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J. Virol. 75:6825-6834.
28. Wei, Y., Y. Zhang, U. Derewenda, X. Liu, W. Minor, R. K. Nakamoto, A. V. Somlyo, A. P. Somlyo, and Z. S. Derewenda. 1997. Crystal structure of RhoA-GDP and its functional implications. Nat. Struct. Biol. 4:699-703.
29. Witvrouw, M., and E. DeClercq. 1997. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen. Pharmacol. 29:497-511.
30. Zhao, X., M. Singh, V. N. Malashkevich, and P. S. Kim. 2000. Structural characterization of the human respiratory syncytial virus fusion protein core. Proc. Natl. Acad. Sci. USA 97:14172-14177.